SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

A decent increase of about 26.79% in the sales to Rs. 3009.88 millions was observed for the quarter ended September 2021. The sales figure stood at Rs. 2373.88 millions during the year-ago period.Handsome Net Profit growth of 76.34% reported above the corresponding previous quarter figure of Rs. 1151.98 millions to Rs. 653.29 millions.OP of the company witnessed a marginal growth to 1601.10 millions from 982.29 millions in the same quarter last year.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202109 202009 % Var 202109 202009 % Var 202103 202003 % Var
Sales 3009.88 2373.88 26.79 5647.89 4756.20 18.75 10097.19 8337.90 21.10
Other Income 383.35 3.57 10638.10 441.18 60.96 623.72 142.37 181.17 -21.42
PBIDT 1601.10 982.29 63.00 2805.09 2155.90 30.11 4547.59 3997.59 13.76
Interest 11.75 26.43 -55.54 33.01 53.63 -38.45 91.44 186.62 -51.00
PBDT 1589.35 955.86 66.27 2772.08 2102.27 31.86 4456.15 3810.97 16.93
Depreciation 91.77 75.00 22.36 181.70 145.63 24.77 316.36 235.07 34.58
PBT 1497.58 880.86 70.01 2590.38 1956.64 32.39 4139.79 3575.90 15.77
TAX 345.60 227.57 51.87 623.99 491.04 27.08 1053.32 875.10 20.37
Deferred Tax 17.80 11.18 59.21 24.56 1.78 1279.78 36.17 -12.99 -378.44
PAT 1151.98 653.29 76.34 1966.39 1465.60 34.17 3086.47 2700.80 14.28
Equity 254.57 254.57 0.00 254.57 254.57 0.00 254.57 127.28 100.01
PBIDTM(%) 53.19 41.38 28.55 49.67 45.33 9.57 45.04 47.94 -6.06

Cohance Lifesciences Share Price

391.60 28.35 (7.80%)
17-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1675.20
Dr. Reddys Lab 1235.40
Cipla 1238.30
Zydus Lifesciences 942.55
Lupin 2324.25
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×